Fenwick represented SyntheX on the deal.SyntheX, a biotechnology company innovating next-generation functional drug discovery engines, announced its research collaboration and license agreement with Bristol Myers Squibb…
SyntheX’s Research Collaboration with Bristol Myers Squibb
![](https://globallegalchronicle.com/wp-content/uploads/2022/10/synthexs-research-collaboration-with-bristol-myers-squibb_633e55e2a270b.jpeg)